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Metabolic and physiological effects of ingesting
extracts of bitter orange, green tea and guarana at
rest and during treadmill walking in overweight males
C Sale, RC Harris, S Delves and J Corbett
School of Sport, Exercise and Health Sciences, University of Chichester, College Lane, West Sussex, UK
Objective: This study examined the acute effects of ingesting a widely used commercial formula containing extracts of bitter
orange, green tea and guarana (Gx) on the metabolic rate and substrate utilisation in overweight, adult males at rest (study 1)
and during treadmill walking (study 2).
Subjects: Two different groups of 10 sedentary males with more than 20% body fat participated in studies 1 and 2.
Design: In each study, subjects participated in two experimental trials during which they were given two 500 mg capsules
containing either Gx or a placebo (P) in a counterbalanced double-blind manner. Doses of the main active ingredients were
6 mg of synephrine, 150 mg caffeine and 150 mg catechin polyphenols.
Measurements: In study 1, subjects completed 7 h supine rest with baseline measures taken during the first hour, with expired
gases, blood pressure, heart rate and venous blood being collected every 30 min for the remaining 6 h following ingestion of Gx
or P. In study 2, subjects exercised for 60 min at 60% heart rate reserve following ingestion of Gx or P 1 h previously. Venous
blood samples were collected twice at rest and at 5, 10, 15, 20, 30, 40, 50 and 60 min, with expired gas measurements taken at
4, 9, 14, 19, 29, 39, 49 and 59 min. In both studies, venous blood was analysed for NEFA, glycerol, glucose and lactate
concentrations, while expired gases were used to calculate ATP production from carbohydrate and NEFA, as well as the total
substrate utilised.
Results and conclusion: The results did not show any significant effect of Gx ingestion on total ATP utilisation during 6 h rest or
during 60 min treadmill walking. Changes were observed in the relative contributions of CHO and NEFA oxidation to ATP
production in both studies, such that there was an increase in ATP production from CHO and a decrease from NEFA. The
increase in CHO oxidation was shown to be as high as 30% at rest.
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Introduction
A positive energy balance is associated with weight gain and
ultimately obesity1 and can arise from an elevated energy
intake, a reduced energy expenditure or a combination of
the two. Spraul et al.2 identified a role for reduced
sympathetic nervous system activity in bodyweight gain,
which increases susceptibility to obesity. Recent data has
suggested that obese individuals exhibit significantly lower
sympathetic nervous system activity in response to various
physiological challenges, such as food intake3 and capsaicin
intake.4
These results would suggest that overweight individuals
might be treated effectively with the use of sympathomi-
metic agonists. Indeed, several commercially available
supplements, containing ephedrine and ephedra, have been
used for this purpose with some success.5 However, recent
reports have identified numerous possible problems with
these supplements including an increased risk of psychiatric,
autonomic and gastrointestinal symptoms, as well as heart
palpitations.5 These problems have led to the development
of non-ephedra-based supplements containing bitter orange
(also known as citrus aurantium), green tea-leaf extract and
guarana (Gx).
Bitter orange extract contains a combination of five
adrenergic amines: synephrine, N-methyltyramine, horde-
nine, octopamine, and tyramine.6 These amines are thought
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to stimulate b3-adrenoreceptors, which have been impli-
cated in the control of various metabolic processes by
catecholamines.7 Bitter orange ingestion is thought to result
in catecholamine release in the vicinity of b3-adrenorecep-
tors located primarily in the adipose tissue and liver. As a
result, bitter orange ingestion is purported to promote
weight loss and increased thermogenesis,5 while having a
minimal effect on blood pressure and heart rate.8
Green tea-leaf extract contains several polyphenolic
compounds that help to prevent the degradation of nor-
adrenaline.9 Green tea and Gx also provide a source of
caffeine (a methylxanthine), which is often added to weight
loss supplements to enhance plasma catecholamine levels
and inhibit transcellular phosphodiesterase. Thus, the
combination of these polyphenolic compounds and caffeine
are reported to be effective in stimulating thermogenesis by
removing the inhibition at different control points along the
nor-adrenaline–cAMP axis.9 Dulloo et al.10 showed that
100 mg of caffeine resulted in a 3–4% increase in metabolic
rate over 150 min. In a later study, Dulloo et al.11 showed an
increase in energy expenditure (an average of 4% over 24 h)
and a 40% increase in urinary nor-adrenaline secretion over
the same time period following ingestion of green tea
extract.
A shift towards positive energy balance may also reflect
reduced physical activity levels.1 Bell et al.12 reported an
attenuated sympathetic nervous system activity in those
with a sedentary lifestyle. Indeed, recent data suggest that
exercise significantly improves sympathetic nervous system
activity in obese subjects.13 In addition, exercise (particularly
at moderate intensities of B65% VO2 peak) is associated with
a higher rate of fat metabolism.14
However, stimulation of sympathetic activity by pharma-
cological means could affect both carbohydrate (CHO) and fat
metabolism and it is by no means clear which effect will
dominate. This could define the usefulness of commercial
formula as an aid to weight loss. The aim of the present
investigation was achieved by conducting two separate
studies to examine the acute effects of ingesting a widely
used commercial formula containing extracts of bitter orange,
green tea and guarana on metabolic rate and substrate
utilisation in overweight, adult males at rest (study 1) and
during treadmill walking at 60% heart rate reserve (study 2).
Methods
Subjects
Ten sedentary, overweight, non-smoking, male subjects
participated in study 1 (mean7s.d. age 2574 years; height:
1.7270.07 m and body mass 83.9716.2 kg), with a different
cohort of 10 sedentary, overweight, male subjects participa-
ting in study 2 (mean7s.d. age 2777 years, height:
1.7170.1 m, body mass 87.9717.1 kg). Selection criteria for
inclusion into both studies were (a) body fat in excess of 20%,
(b) sedentary and (c) clinically normal when assessed using
12-lead ECG, blood screening and health history question-
naire. The Ethics Review Committee of University of
Chichester approved both studies and all subjects provided
their written informed consent before participation.
Experimental design
Study 1. Each subject participated in a preliminary assess-
ment and two experimental trials, with subjects being
given either Gx (Xenadrine-EFXt, Cytodyne Technologies
Inc., Table 1) or a matching placebo (P) in each trial.
The preliminary assessment was always conducted first in
order to confirm that subjects met the selection criteria
for the study. The effects of Gx and P on metabolic rate
and substrate utilisation were examined over 7 h following
the ingestion of a light breakfast. Throughout, subjects
were tested in pairs, with one administered Gx and the
other P, using a counterbalanced, double-blind, experimen-
tal design.
Study 2. Each subject participated in one preliminary
assessment and two experimental trials (Gx and P). The
preliminary assessment was always conducted first in order
to confirm that subjects met the selection criteria for the
study. In each experimental trial (separated by a minimum of
48 h) subjects exercised for 60 min at 60% of their maximal
heart rate reserve (HRR) following the ingestion of either Gx
(Table 1) or P. Trials were conducted using a counter-
balanced, double–blind, experimental design.
Table 1 Table of ingredients
Ingredient Amount per capsule
Vitamin C 100 mg
Vitamin B6 10 mg
Pantothentic acid 12 mg
Magnesium 10 mg
Thyroplex proprietary blend 1415 mg, containing
Bitter orange
Green tea extract
Gx
L-Tyrosine
Acetyl-L-tyrosine
Theobroma cacao extract Standardised for synephrine
3 mg, caffeine 75 mg and
catechin polyphenols 75 mg
DL-Methionine
Ginger Root
Quercetin
Fisetin
2-Dimethylaminoethanol
Grape seed extract
Pyridoxine Hydrochloride
Proprietary ingredients were standardised for caffeine, synephrine and
catechin polyphenols, which was confirmed by independent analysis from
Phoenix Laboratories Ltd, Farmingdale, NY, USA.
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Experimental procedures study 1
Baseline resting metabolic rate (BRMR). Before the start of the
first experimental trial, subjects reported to the laboratory
at 0900 hours for a 1 h baseline assessment following an
overnight fast. With the subject resting in the supine
position, expired gases were collected into Douglas bags
over 5 min, separated by 10 min intervals (between 20–25
and 30–35 min). During this time, the mouthpiece and
nose-clip remained in position. A third 5 min expired gas
collection was taken (between 40 and 45 min) if the
estimates of oxygen consumed (VO2) from the first two
collections differed by more than 5%.15 BRMR was calculated
from the two lowest consecutive values obtained in each
case. Heart rate and blood pressure were recorded immedi-
ately after each period of gas collection.
Experimental trials. For the two trials, subjects reported to
the laboratory at 1100 hours following a standard breakfast
taken at 0700 hours (comprising two slices of toast with jam,
two boiled eggs, orange juice and water). Subjects were asked
to refrain from alcohol, caffeine and exercise for 48 h before
each laboratory visit. In addition, subjects were requested to
complete a 24 h dietary record on the day before the first
laboratory visit and to follow the same dietary pattern before
the second visit. Compliance with these experimental
controls was verbally confirmed with the subjects before
commencing each experimental session.
Height and body mass were recorded, a heart rate monitor
(Polar Night Vantage, Oy, Finland) fitted and an indwelling
cannula inserted into a forearm vein on each attendance.
Subjects underwent 7 h of supine rest in an environmental
chamber set at 241C and 50% relative humidity. During
the first hour of supine rest, expired gases were collected
between 25–30 and 55–60 min. Following the 60 min gas
collection, subjects orally ingested either two 500 mg
capsules of Gx or a matching P. Thereafter, expired gases,
blood pressure, heart rate and venous blood (10 ml) were
collected over the final 5 min in every 0.5 h for the
remaining 6 h.
Experimental procedures study 2
Preliminary assessment. Subjects reported to the laboratory
at 0900 hours for baseline assessment, following an over-
night fast. Subjects were rested in the supine position for
0.5 h, following which ECG and blood pressure measure-
ments were taken. Skinfold thicknesses at four sites (bicep,
tricep, sub-scapula and supra-iliac) were measured, using
Harpenden skinfold callipers, for the subsequent calculation
of body fat percentage.16 Subjects were also exercised on a
treadmill in order to determine the treadmill speed and
gradient eliciting 60% of maximal heart rate reserve.
Experimental trials. In conditions Gx and P, subjects reported
to the laboratory at 1100 hours following a standard breakfast
taken at 0700 hours (comprising two slices of toast with
spread and jam, two boiled eggs, orange juice and water).
Subjects were asked to refrain from alcohol, caffeine and
exercise for 48 h before each laboratory visit. In addition,
subjects were requested to complete a 24 h dietary record on
the day before the first laboratory visit and to follow the same
dietary pattern before the second visit. Compliance with
these experimental controls was verbally confirmed with the
subjects before commencing each experimental session.
Upon presentation to the laboratory, subjects height and
body mass were recorded, a heart rate monitor (Polar Night
Vantage, Oy, Finland) fitted and an indwelling cannula
inserted into a prominent forearm vein. The cannula was
maintained patent by infusion of saline (without the
addition of heparin).
Following 30 min rest, a pre-exercise blood sample (10 ml)
was drawn for measurement of NEFA, glycerol, glucose and
lactate. Subjects then ingested either Gx or P and further
blood samples were taken at 30 and 5 min before exercise.
Subjects exercised on a treadmill for 60 min, at the pre-
determined speed and incline sufficient to elicit 60% of
maximal heart rate reserve. Further, blood samples (10 ml)
were taken at 5, 10, 15, 20, 30, 40, 50 and 60 min and expired
air (inspiration to inspiration) was collected between 4–5,
9–10, 14–15, 19–20, 29–30, 39–40, 49–50 and 59–60 min.
General methods
Oxygen consumption, estimation of resting metabolic rate and
substrate utilisation. Expired gases were collected using
Douglas bags and were analysed by first saturating with
water by passing through 50 cm of Nafian tubing (Omnifit
Ltd, Cambridge, UK) immersed in distilled water. Thereafter,
expired gases were passed through a Bu¨hle condenser at
5.070.11C (Bu¨hler PKE 3; Paterson Instruments, Leighton
Buzzard, UK) and analysed as described by Draper et al.,17
using a Servomex series 1400 Paramagnetic Oxygen Analyser
(Servomex Plc., Crowborough, UK), a Servomex InfraRed
Carbon Dioxide Analyser (Servomex Plc., Crowborough, UK)
and a Harvard Dry Gas Meter (Harvard, Edenbridge, UK). Gas
analysers were calibrated against 100% nitrogen (0% O2) and
atmospheric air, with a gas sample of known concentration
(Linde Gas, Stratford, UK) being used to verify the calibra-
tion. Measured volumes of oxygen and carbon dioxide were
adjusted to standard temperature and pressure dry.
.
VO2 is
the oxygen consumed (litres) and RER is the respiratory
exchange ratio. The coefficient of variation of
.
VO2, VCO2
and RER, determined in a pilot study, was less than 5%.
Measurements of expired gases were used to calculate
metabolic rates and rates of substrate oxidation, according to
%O2 utilised for CHO oxidation ¼ ðRER 0:696Þ328:9
ð1Þ
mol ATP from oxidation of
CHO ðATPCHOÞ ¼ ð
.
VO2=22:415Þð%O2 CHO=100Þ6:333
ð2Þ
Effects of bitter orange, green tea and guarana
C Sale et al
766
International Journal of Obesity
NEFA ðATPNEFAÞ ¼ð
.
VO2=22:415Þð1 ð%O2 CHO=100ÞÞ5:609
ð3Þ
Total ðATPTOTALÞ ¼ ð2Þ þ ð3Þ ð4Þ
Equations (2) and (3) are based on the oxidation of glucose
and palmitate as the sole substrates utilised. Equation (2)
assumes 38 molATP and equation (3) 129 mol ATP generated
per mol of glucose and palmitate oxidised, respectively. The
amounts of CHO (glucose) and fat (palmitate) oxidised over
each period were calculated from:
g CHO ¼ ð .VO2=22:415Þð%O2 CHO=100Þ30 ð5Þ
g NEFA ¼ð .VO2=22:415Þð1 ð%O2 CHO=100ÞÞ11:148 ð6Þ
The estimates assume that the oxidation of protein was
minimal, and that in study 2, the blood lactate increase had
minimal effect on blood pH and bicarbonate equilibrium. In
the text, it was assumed that the free energy from ATP
hydrolysis (DG) at circa pH 7 (i.e. metabolisable energy or
ME) is 70 kJ/mol18 assuming a DG0 of 40.2 kJ.19
Plasma analyses. Each 10 ml venous blood sample was
aliquoted into two separate blood collection tubes coated
with EDTA. Samples were immediately centrifuged for 5 min
at 5000 r.p.m. at a temperature of 41C. Plasma was separated
and stored at 801C until required for analysis. Plasma NEFA
and glycerol concentrations were determined using enzymic-
colourimetric methods from Wako Chemicals (Neuss,
Germany) and Randox Laboratories (Crumlin, Co Antrim,
UK), respectively. Plasma glucose and lactate were analysed
using an automatic analyser (YSI 2300 STAT, Yellow Springs
Instruments, OH, USA).
Statistical methods. All data from both studies are presented
as means7s.d., with statistical significance accepted at the
Po0.05 level, unless otherwise stated.
For study 1, changes in the concentrations of metabolites
(NEFA, glycerol, glucose and lactate) over time were analysed
by repeated measures ANOVA. Where an effect of treatment
was observed (NEFA), the average concentration over the
final 3 h of the study was computed for each subject and the
mean within-subject difference was compared by Student’s
t-test for paired data.
The mean within-subject differences of the average rate of
ATP turnover and total turnover for the stated period were
analysed using Student’s t-test for paired data. For purposes
of clarity, rates of ATP turnover measured at the half-hourly
times in study 1 have been omitted in Figures 1 and 2 (panel
a in each figure). However, the half-hourly rates were used in
calculating the total ATP turnover by the end of each hour
(panel b in each figure), although ATP turnover by the end of
each half-hour is itself again not shown. Similarly in Figures
3 and 4, rates at 5 and 15 min of exercise have been omitted
for reasons of clarity (panel a in each figure), although these
rates were included when calculating ATP used by the end of
each 10th min of exercise (panel b in each figure).
Results
The results from one subject who consistently hyperventi-
lated during collection of expired air and whose data for RER
was erratic (with some values above 1.00), were omitted from
the final analyses in both studies.
Study 1
BRMR following an overnight fast was 73.177.9 mmol
ATP min1 (corresponding to an ME of 5.1270.55 kJ min1),
with 56.0% of the ATP produced being from the oxidation of
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Figure 1 (a) The mean rate of ATP (mmol min1) production from
carbohydrate oxidation (ATPCHO) during 6 h of rest following administration
of Gx or P at 0 h. The upper inset panel shows the mean (þ s.d.) within-
subject difference due to treatment at each of the time points. Half-hourly
values have been omitted for reasons of clarity. (b) The mean total ATPCHO
(mol) produced by the end of each hour. The mean difference (þ s.d.)
between treatments in total ATPCHO is shown in the lower inset panel. The
effect of treatment was significant from 3 h onwards. *A Student’s t-value of
42.306, which was significant (Po0.05) with 8 degrees of freedom. Half-
hourly values are again not shown although half-hourly rates were used when
calculating the total produced by the end of each hour.
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CHO (Table 2). Glucose and NEFA oxidation rates were
0.19470.074 and 0.06470.028 g min1. Mean total ATP
turnover and CHO and fat oxidation rates at rest at the start
of the two experimental sessions were close to the estimates
of BRMR despite the intake of a light breakfast four hours
earlier.
Mean (7s.d.)
.
VO2 (ml min
1) and RER following Gx or P
are presented in Table 3. The estimated 1-min rate of ATP
production from CHO oxidation ATPCHO, measured every
30 min, decreased reaching a nadir with treatment P at 3 h
(25.5719.1 mmol ATP min1, Po0.01) (Figure 1, panel a).
A similar decrease occurred with Gx but to a lesser extent.
The influence of Gx on ATPCHO appeared to be greatest
between 1.5 and 3 h; the mean within-subject difference in
rates was significant at 1.5 and 2.5 h. Total ATPCHO over the
6 h, and the difference between treatments, are shown in
Figure 1, panel b. The effect of Gx was significant (Po0.05)
from 3 h onwards. Following Gx, an additional 13.3713.0 g
of glucose was oxidised over the 6 h, with the production of
an extra 2.8072.75 mol ATP.
In contrast, the rate of ATP production from NEFA
oxidation (ATPNEFA), in both conditions, increased through-
out the 6 h period (Figure 2, panel b) and was comparable
with the reduction in ATPCHO. In condition P, the increase
peaked at 3 h (Po0.01 compared to the 0 h rate). With Gx,
the increase in ATPNEFA was less, although the difference
between treatments was not significant. Accumulative
ATPNEFA over the 6 h was not significantly different between
Gx and P (P40.05). The mean change in NEFA oxidation
with Gx relative to P was 5.8713.7 g over the 6 h period.
The sum of ATP from CHO and NEFA oxidation (ATPTOTAL)
by the end of the 6 h was the same with the two treatments
(Gx¼27.2973.47 and P¼27.1072.38 mol).
Plasma NEFA concentrations increased following Gx and P
over the 6 h (Table 4). Between 3–6 h the increase in plasma
NEFA following Gx was as a mean þ76.3759.2 mmol l1
greater than with P (Po0.01). Plasma glycerol increased with
both treatments but in this case to an equal extent (Table 4).
There was no effect of treatment on plasma glucose or lactate
concentrations (Table 4). Similarly, there was no effect of
treatment on blood pressure or heart rate (Figure 3).
Study 2
Changes in
.
VO2 and RER during the 60 min walking exercise
are shown in Table 5.
The onset of exercise resulted in a nine-fold increase in
ATPCHO from 42.0729.1 to 371.37105.1 mmol min
1 at
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Figure 2 (a) The mean rate of ATP (mmol min1) production from NEFA
oxidation (ATPNEFA) during 6 h of rest following administration of Gx or P at
0 h. The upper inset panel shows the mean (s.d.) within-subject difference
due to treatment at each of the time points. Half-hourly values have been
omitted for reasons of clarity. (b) Mean total ATPNEFA (mol) produced by the
end of each hour. The mean difference (s.d.) between treatments in total
ATPNEFA is shown in the lower inset panel. Half-hourly values are again not
shown, although half-hourly rates were used when calculating the total
produced by the end of each hour.
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Figure 3 Systolic and diastolic blood pressure, and heart rate, during 6 h rest
in the supine position, following administration of Gx or P at 0 h.
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5 min with treatment P. Thereafter, the ATPCHO rate tended
to fall reaching 334.0790.2 mmol min1 at 60 min (Figure 4,
panel a). Following ingestion of Gx, the rate of ATPCHO was
higher than with P during the 60 min walking exercise. The
difference in treatments was significant (Po0.05) at the 20-
and 30-min measurements. Total ATPCHO was significantly
greater with Gx from 20 min of exercise onwards (Figure 4,
panel b), resulting in an additional utilisation of
2.4772.73 mol by the end of 60 min. This corresponds to
an additional oxidation of 11.7712.9 g of CHO.
At the 5th min of exercise, ATPNEFA was increased 4.5-fold
in condition P from 38.3716.8 to 173.5761.6 mmol min1.
Thereafter, the rate continued to increase reaching
267.5790.0 mmol min1 at 60 min (Figure 5, panel a).
Following Gx administration, the rate of ATPNEFA was lower
at each time point and was significant at 20- and 50-min
measurements. The effect was a lower total ATPNEFA, with the
difference between treatments (1.9272.23 mol) approaching
significance (0.06oPo0.08) between the 30th and the 60th
min (Figure 5, panel b). The estimated reduction in fat
oxidised by 60 min was 3.875.1 g.
Quantitatively, the fall in ATPNEFA with Gx matched the
increase in ATPCHO with the result that total ATP utilised by
the end of the 60 min was the same for the two treatments
(P¼34.973.9 and Gx¼35.473.3 mol).
There was no effect of Gx on the exercise-induced
increases in plasma glycerol or NEFA concentrations,
indicating similar lipid mobilisation with Gx and P (Table 6).
Similarly, there was no significant effect of Gx ingestion on
plasma glucose and lactate concentrations (Table 6) or on
heart rate.
Discussion
Gx had no effect on total ATP utilisation in the resting state.
These results, based as they are on the use of a proprietary
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Figure 4 (a) The mean rate of ATP (mmol min1) production from
carbohydrate oxidation (ATPCHO) during 60 min of exercise following
administration of Gx or P at 0 min. The upper inset panel shows the mean
(þ s.d.) within-subject difference due to treatment at each of the time points.
Values recorded at 5 and 15 min have been omitted for reasons of clarity. The
difference between treatments at 20 and 30 min was significant (Po0.05). (b)
The mean total ATPCHO (mol) produced by the end of each period of exercise.
The mean difference (þ s.d.) between treatments in total ATPCHO is shown in
the lower inset panel. The effect of treatment was significant from 20 min
onwards. (Po0.05). Values at 5 and 15 min are again not shown, although the
rates at these times were used when calculating the total produced by the end
of 10 and 20 min, respectively.
Table 2
.
VO2, RER and estimates of ATP from oxidation of carbohydrate
(ATPCHO) and NEFA (ATPNEFA), as well as the actual amounts of carbohydrate
and NEFA oxidised, per minute in the resting state following an overnight fast
(BRMR), or, immediately before administration of Gx or P (0 h RMR)
BRMR 0 h RMR
Mean 7s.d. Mean 7s.d.
.
VO2 (ml min
1) 274 29 281 32
RER 0.863 0.061 0.866 0.041
CHO oxidized (g min1) 0.194 0.074 0.208 0.059
NEFA oxidized (g min1) 0.064 0.028 0.063 0.035
ATPCHO (mmol min
1) 40.9 15.6 43.9 12.5
BRMR and 0 h RMR are the mean in each case of the average of two
measurements made in each subject.
Table 3
.
VO2 and RER at each hour during 6 h rest in the supine position,
following administration of Gx or P at 0 h
Time (h) 0 1 2 3 4 5 6
.
VO2 (ml min
1)
Gx
Mean 273 289 289 288 287 291 296
7s.d. 30 40 40 43 49 41 39
P
Mean 289 297 287 289 291 290 298
7s.d. 44 34 35 25 37 27 36
RER
Gx
Mean 0.867 0.842 0.823 0.799 0.82 0.797 0.84
7s.d. 0.055 0.042 0.045 0.024 0.052 0.027 0.068
P
Mean 0.864 0.814 0.789 0.768 0.792 0.786 0.806
7s.d. 0.072 0.051 0.039 0.045 0.038 0.03 0.034
To simplify the table, half-hourly values have been omitted, although these
were used in the calculations of ATP turnover and substrate utilisation.
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product (containing 6 mg of synephrine, 150 mg caffeine
and 150 mg catechin polyphenols), differ from those of
Dulloo et al.,11 who reported an effect of þ4% on 24 h
energy expenditure using a combination of green tea extract
and caffeine. Caffeine alone (100 mg) increased the meta-
bolic rate by 3–4% over 150 min in lean and post-obese
subjects, and by 8–11% over a 12 h period with repeated
caffeine administration.10 Similarly, Koot and Deurenberg20
reported a 7% increase in RMR over 3 h with 200 mg caffeine.
Bracco et al.21 reported increases of 4.8% in obese and 7.6%
in lean subjects during 24 h energy expenditure measure-
ment following coffee ingestion. The increases in energy
expenditure in these studies were attributed to greater lipid
oxidation with or without any increase in CHO oxidation.
Acheson et al.22 observed a significantly increased metabolic
rate following caffeine ingestion (4 and 8 mg kg1) in
subjects of normal weight, which was accounted for by
greater lipid oxidation, although they showed a reduced
effect on fat oxidation in obese subjects. Similarly, Colker
et al.23 showed an average daily increase of 2–3% in basal
Table 4 Plasma NEFA, glycerol, glucose and lactate concentrations during
6 h rest in the supine position, following administration of Gx or P at 0 h
Time (h) 0 1 2 3 4 5 6
NEFA (mmol l1)
Gx
Mean 88 229 284 395 396 374 406
7s.d. 37 93 123 94 78 99 81
P
Mean 81 171 218 288 282 293 303
7s.d. 37 67 60 73 68 72 84
Glycerol (mmol l1)
Gx
Mean 312 551 570 653 701 676 609
7s.d. 129 206 206 182 210 189 165
P
Mean 294 490 529 585 583 595 611
7s.d. 116 188 174 160 128 141 144
Glucose (mmol l1)
Gx
Mean 5.28 5.17 5.11 5.01 4.96 4.85 4.83
7s.d. 0.40 0.25 0.33 0.23 0.26 0.25 0.24
P
Mean 5.12 5.07 5.06 4.97 4.88 4.85 4.79
7s.d. 0.40 0.34 0.32 0.32 0.25 0.23 0.18
Lactate (mmol l1)
Gx
Mean 0.73 0.74 0.79 0.81 0.78 0.86 0.85
7s.d. 0.28 0.29 0.32 0.32 0.30 0.34 0.34
P
Mean 0.79 0.73 0.78 0.74 0.72 0.71 0.75
7s.d. 0.32 0.30 0.31 0.30 0.28 0.28 0.30
To simplify the table, half-hourly values have been omitted.
Table 5
.
VO2 and RER during 60 min walking exercise at 60% heart rate
reserve, following administration of Gx or P at 0 min
Time (min) 0 10 20 30 40 50 60
.
VO2 (ml min
1)
Gx
Mean 273 2073 2129 2105 2068 2071 2132
+s.d. 29 307 297 343 394 380 434
P
Mean 301 2045 2146 2078 2097 2094 2143
+s.d. 46 317 271 360 381 398 427
RER
Gx
Mean 0.862 0.905 0.915 0.886 0.876 0.886 0.858
+s.d. 0.060 0.035 0.032 0.045 0.035 0.035 0.031
P
Mean 0.847 0.897 0.888 0.872 0.875 0.857 0.860
+s.d. 0.072 0.053 0.047 0.039 0.044 0.037 0.041
To simplify the table, values at 5 and 15 min have been omitted.
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Figure 5 (a) The mean rate of ATP (mmol min1) production from NEFA
oxidation (ATPNEFA) during 60 min of exercise following administration of Gx
or P at 0 min. The upper inset panel shows the mean (s.d.) within-subject
difference owing to treatment at each of the time points. Values recorded at 5
and 15 min have been omitted for reasons of clarity. The difference between
treatments at 20 and 50 min was significant (Po0.05). (b) The mean total
ATPNEFA (mol) produced by the end of each period of exercise. The mean
difference (s.d.) between treatments in total ATPNEFA is shown in the lower
inset panel. The effect of treatment was just outside significance from 30 min
onwards (0.06oP 0.08). Values at 5 and 15 min are again not shown,
although the rates at these times were used when calculating the total
produced by the end of 10 and 20 min, respectively.
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metabolic rate following the ingestion of 975 mg of citrus
aurantium and 528 mg of caffeine when compared to both
placebo and control conditions.
Gx again appeared to have no effect on total ATP
utilisation during light exercise (study 2). Based on the use
of a proprietary product with several active ingredients (6 mg
of synephrine, 150 mg caffeine and 150 mg catechin poly-
phenols), these results differ from those of Engels et al.,24
who reported a significant effect of caffeine ingestion
(5 mg kg1) on the rate of energy expenditure during
60 min exercise at 30%
.
VO2max, although there was no
change in RER. Engels et al. used higher doses of caffeine
than were administered in this study (150 mg) but exercised
subjects at a lower intensity. In respect of the other
ingredients present in Gx, the authors are not aware of any
studies investigating the effects of green tea or bitter orange
ingestion on energy expenditure during exercise.
While Gx appeared to have no effect on total energy
expenditure in either condition, it did appear to stimulate
ATP production from CHO oxidation relative to treatment P,
which in both conditions was balanced by a fall in ATP from
fat oxidation. In the resting, state the net gain in ATPCHO
over the 6 h corresponded to an additional 13.3713.0 g of
CHO oxidised over and above a total of 44.7712.1 g oxidised
during this period with P (a 30% increase). The decline in
ATPNEFA over the same 6 h corresponded to a reduction of
5.8713.7 g of fat oxidised against 35.177.4 g oxidised
during this period with P (a 13% decrease). The greater
increase in the plasma NEFA concentration observed with Gx
could be interpreted as resulting from both an increase in
lipid mobilisation or a decrease in oxidation. However, given
the similar increases in plasma glycerol and the apparent fall
in ATPNEFA with Gx, then the latter would seem the most
likely explanation. The trend towards higher plasma lactate
concentrations following Gx is again indicative of an
increase in CHO metabolism, possibly in muscle.
Despite an almost identical metabolic rate with Gx and P
in study 2, there was again a significant increase in the
contribution of CHO oxidation to total energy expenditure.
This coincided with a reduction in the contribution from fat
oxidation. Thus, in both resting (study 1) and exercising
(study 2) conditions, the ingestion of Gx resulted in an
increase in the relative contribution of CHO to energy
expenditure, and a decrease in fat oxidation. In study 2, the
change in both plasma NEFA and glycerol concentrations
were lower following Gx ingestion, possibly indicating, in
this instance, a reduced NEFA mobilisation when compared
with P ingestion.
The proprietary ingredients of Xenadrine-EFXt (contain-
ing 6 mg of synephrine, 150 mg caffeine and 150 mg
catechin polyphenols) have the potential to affect metabo-
lism in several different ways. EGCG, caffeine and the
adrenergic amines found in bitter orange extract are likely
to increase sympathetic activity by prolonging the half-life
in tissues of nor-adrenaline and cAMP. Increased expression
of sympathetic activity would be expected to increase NEFA
release from adipose tissue by stimulation of lipoprotein
lipase.25,26 However, they also have the potential to
stimulate CHO metabolism by activation of glycogen
phosphorylase.27,28 In contrast to this, caffeine may even
attenuate glycogenolysis through an inhibitory effect on
glycogen phosphorylase transformation.29,30 The effects of
increased cAMP on different enzyme systems, however, will
be moderated by allosteric control mechanisms within the
metabolising cells in order to balance ATP production with
demand. While this still does not establish that increased
sympathetic activity would necessarily increase RMR, spe-
cific b1-31 and non-specific (b1- and b2-)32 antagonists have
been shown to reduce the metabolic rate at rest. This does
not appear to be mediated through the thermogenic
hormone triiodothyronine.32 Further stimulation of RMR
through caffeine-induced release of the effect of adenosine,
acting as a prejunctional inhibitor, would be additional to
any direct metabolic effects. Surprisingly, there was no effect
of Gx on resting heart rate or blood pressure despite the fact
that Gx contains approximately 6 mg of synephrine, 150 mg
caffeine and 150 mg catechin polyphenols, which might
have been expected to have an effect.
Table 6 Plasma NEFA, glycerol, glucose and lactate concentrations during
60 min walking exercise at 60% heart rate reserve, following administration of
Gx or P at 0 min
Time (min) 0 10 20 30 40 50 60
NEFA (mmol l1)
Gx
Mean 88.8 72.6 95.7 124.9 159.9 193.1 208.1
+s.d. 49.0 27.1 43.1 59.0 77.5 104.3 114.0
P
Mean 81.0 68.8 98.8 134.0 160.4 195.0 210.6
+s.d. 57.5 35.9 51.2 66.0 76.5 82.1 85.4
Glycerol (mmol l1)
Gx
Mean 38.8 60.9 85.2 111.8 140.6 163.1 172.6
+s.d. 14.3 17.7 32.6 40.5 48.7 59.3 59.5
P
Mean 35.0 67.4 95.1 130.0 158.0 180.3 199.0
+s.d. 10.2 24.0 46.4 67.3 81.2 88.2 90.3
Glucose (mmol l1)
Gx
Mean 5.15 4.58 4.63 4.71 4.71 4.79 4.72
+s.d. 1.14 1.19 1.25 1.36 1.40 1.43 1.46
P
Mean 4.74 4.56 4.58 4.62 4.58 4.58 4.57
+s.d. 1.48 1.38 1.43 1.51 1.50 1.50 1.48
Lactate (mmol l1)
Gx
Mean 1.33 1.98 1.73 1.57 1.44 1.41 1.32
+s.d. 0.50 0.77 0.70 0.72 0.73 0.70 0.61
P
Mean 1.13 1.58 1.55 1.24 1.07 1.02 1.00
+s.d. 0.53 0.53 0.84 0.47 0.37 0.26 0.22
To simplify the table, values at 5 and 15 min have been omitted.
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It has been reported that the alkaloids in citrus aurantium
result in a stimulation of b3-receptors with less of an
influence on b1- and b2-receptors.5 The b3-receptor seems
to be the most abundant beta subtype in human brown
adipocytes and is thought to play a key role in the lipolytic
and thermogenic effects of adrenergic agents,2,33 without
exerting an effect on those receptors responsible for
cardiovascular control.2 These effects might be consistent
with the results of study 1 in terms of the observed increase
in plasma NEFA minus any significant changes in heart rate
or blood pressure. However, the increase in plasma NEFA
(observed in study 1 but not in study 2) could equally be the
result of a reduced fat oxidation, as mentioned previously.
In addition, these effects would not be consistent with the
increased contribution of CHO oxidation to the elevated
RMR and EMR.
The implications of the present results to the use of Gx for
weight loss are not favourable, in that total metabolic rate
was unchanged. A pharmacological effect was indicated by
the increase in CHO oxidation, matched by a fall in NEFA
oxidation, but these are opposite to the effects usually
promoted for weight-loss products. However, these effects
were recorded following the administration of a single dose
of Gx, whereas different effects on the balance of CHO and
fat oxidation, and the overall metabolic rate, might occur
with repeated ingestion. On the positive side, Gx was not
associated with any measurable changes in blood pressure or
heart rate as previously reported following the administra-
tion of bitter orange extract,8 although this contrasts with
the effects of caffeine.34
The treatment formulation, combining the effects of
EGCG and caffeine to stimulate b1-adrenoreptor activity
seems logical given the link between this and resting
metabolic rate.31 It remains to be seen if chronic adminis-
tration of Gx is effective in stimulating greater loss of weight,
particularly if combined with regular exercise.
Finally, it should be noted that the study was not without
limitations. In attempting to estimate directly the resting
metabolic rate, certain assumptions were made with respect
to substrates utilised. Some glycogen in addition to glucose
may have been oxidised and inevitably oxidation of other
free fatty acids, such as stearate, will have contributed to
overall fat oxidation. However, the effect of such considera-
tions on the calculations is minimal. The assumption is
also made that no protein was oxidised and thus did not
contribute to energy expenditure. In study 2, it is assumed
that loss of bicarbonate through decrease in plasma pH,
caused by lactate increase, was minimal and if it occurred
was equal in the two sessions. This appears to be supported
by the very small changes observed in plasma lactate. Finally,
the method of respiratory gas collections was not ideal and
the use of a mouthpiece may affect sympathetic activity if
this is felt by the subject to increase the resistance to
breathing. Although one subject was clearly affected by this,
with the result that his data from all sessions were with-
drawn, this limitation should have equally affected both
treatment conditions, as it did in the case of this subject (but
to such a gross level in this case as to render the data
incalculable).
We conclude that a single dose of Gx had little or no effect
on total ATP utilisation during 6 h at rest or during 60 min of
light exercise at 60% HRR. Gx ingestion, however, did result
in changes in the relative contributions from CHO and NEFA
oxidation to ATP production in both conditions. At rest, the
increase in CHO oxidation may have been as high as 30%.
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